Tag Archives: respiratory infection

Serious flu gene found

Scientists have identified a genetic flaw that may explain why some people get more ill with flu than others.

Writing in Nature, the researchers said the variant of the IFITM3 gene was much more common in people hospitalised for flu than in the general population.

It controls a malformed protein, which makes cells more susceptible to viral infection.

Experts said those with the flaw could be given the flu jab, like other at-risk groups.

Researchers removed the gene from mice. They found that when they developed flu, their symptoms were much worse than those seen in mice with the gene.

Evidence from genetic databases covering thousands of people showed the flawed version of the gene is present in around one in 400 people.

The scientists, who came from the UK and US, then sequenced the IFITM3 genes of 53 patients who were in hospital with flu.

Three were found to have the variant – a rate of one in 20.

The researchers say these findings now need to be replicated in bigger studies. And they add it is probably only part of the genetic jigsaw that determines a person’s response to flu.

Professor Paul Kellam of the Wellcome Trust Sanger Institute, who co-led the research, said: “At the moment, if someone is in a more vulnerable group because of co-morbidity [another health problem], they would be offered the flu vaccine.

Flu virus

Flu virus

“This is the idea here.”

But he said having this variant would not make any difference to how people were treated.


Prof Kellam added: “Our research is important for people who have this variant as we predict their immune defences could be weakened to some virus infections.

“Ultimately as we learn more about the genetics of susceptibility to viruses, then people can take informed precautions, such as vaccination to prevent infection.”

Professor Peter Openshaw, director of the Centre for Respiratory Infection at Imperial College London, said: “This new discovery is the first clue from our detailed study of the devastating effects of flu in hospitalised patients.

“It vindicates our conviction that there is something unusual about these patients.”

Sir Mark Walport, director of the Wellcome Trust, said: “During the recent swine flu pandemic, many people found it remarkable that the same virus could provoke only mild symptoms in most people, while, more rarely, threatening the lives of others.

“This discovery points to a piece of the explanation: genetic variations affect the way in which different people respond to infection.

“This important research adds to a growing scientific understanding that genetic factors affect the course of disease in more than one way. Genetic variations in a virus can increase its virulence, but genetic variations in that virus’s host – us – matter greatly as well.”

Vitamin A could save lives

Giving vitamin A supplements to children under the age of five in developing countries could save 600,000 lives a year, researchers claim.

Writing in the British Medical Journal, UK and Pakistani experts assessed 43 studies involving 200,000 children, and found deaths were cut by 24% if children were given the vitamin.

And they say taking it would also cut rates of measles and diarrhoea.

The body needs vitamin A for the visual and immune systems to work properly.

It is found in foods including cheese, eggs, liver and oily fish.

The World Health Organization (WHO) estimates that, around the world, 190 million children under the age of five may have a vitamin A deficiency.

But despite widespread efforts, supplementation programmes do not reach all the children who could benefit.

Capsules are now distributed twice a year in at least 60 countries, with average annual coverage rates nearing 80%.

However, University of Oxford and Aga Khan University researchers who carried out this work say the effectiveness of vitamin A is so well-established that policy-makers should provide supplements to all children at risk.

Vitamin A

Vitamin A

They evaluated studies that involved children aged six months to five years, and compared rates of illness and death among those who were given vitamin A and those who were not.

hey found vitamin A supplements reduced child mortality by 24% in low- and middle-income countries.

They calculate that, considering the estimated 190m children who are vitamin A deficient, reducing deaths by 24% would save more than 600,000 lives each year.


Dr Evan Mayo-Wilson from the University of Oxford, who worked on the study, said: “Until other sources are available, supplements should be given to all children who are at risk of vitamin A deficiency.

“After just one year, children who had taken supplements were less likely to have died than children who received a placebo [dummy version].

Vitamin A supplements are highly effective and cheap to produce and administer.”

He said there had been recent criticism of vitamin A programmes – with some saying there were risks that respiratory infection rates could increase, particularly in children who were not vitamin A deficient – but he added there was “little doubt” that vitamin A prevented young children from dying.